Compare · SXI vs TMO
SXI vs TMO
Side-by-side comparison of Standex International Corporation (SXI) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SXI and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.53B, about 78.6x SXI ($3.28B).
- Over the past year, SXI is up 13.9% and TMO is up 28.0% - TMO leads by 14.2 points.
- TMO has been more active in the news (7 items in the past 4 weeks vs 4 for SXI).
- TMO has more recent analyst coverage (25 ratings vs 7 for SXI).
- Company
- Standex International Corporation
- Thermo Fisher Scientific Inc
- Price
- $265.03-0.81%
- $690.13-0.92%
- Market cap
- $3.28B
- $257.53B
- 1M return
- +2.75%
- +4.77%
- 1Y return
- +13.85%
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 4
- 7
- Recent ratings
- 7
- 25
Standex International Corporation
Standex International Corporation, together with subsidiaries, manufactures and sells various products and services for commercial and industrial markets in the United States and internationally. The company operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics segment offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, and custom electronics sensors; and current sense and advanced planar transformer technologies, value added assemblies, and mechanical packaging, as well as custom wound transformers and inductors for low and high frequency applications. The Engraving segment provides mold texturizing, slush molding tools, roll engraving, hygiene product tooling, and low observation vents, as well as project management and design services for stealth aircraft; and process machinery for various industries. The Scientific segment offers temperature controlled equipment for the medical, scientific, pharmaceutical, biotech, and industrial markets. The Engineering Technologies segment offers net and near net formed single-source customized solutions that are used in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets. The Specialty Solutions segment manufactures and sells refrigerated, heated and dry merchandizing display cases, custom fluid pump solutions, single and double acting telescopic, and piston rod hydraulic cylinders. Standex International Corporation was founded in 1955 and is headquartered in Salem, New Hampshire.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SXI
- Analyst initiated coverage on Standex International with a new price target
- Director Chorman Thomas E sold $13,570 worth of shares (50 units at $271.39) as part of a pre-agreed trading plan, decreasing direct ownership by 0.41% to 12,266 units (SEC Form 4)
- VP & Chief Accounting Officer Rangel Danielle was granted 6 shares, increasing direct ownership by 2% to 339 units (SEC Form 4)
- VP; Chief Information Officer Arets Max was granted 11 shares, increasing direct ownership by 0.67% to 1,652 units (SEC Form 4)
- STANDEX TO PARTICIPATE IN D.A. DAVIDSON INDUSTRIALS & SERVICES CONFERENCE
- VP; Chief Information Officer Arets Max bought $12,328 worth of shares (45 units at $273.96), increasing direct ownership by 3% to 1,641 units (SEC Form 4)
- SEC Form DEF 14A filed by Standex International Corporation
- Director Chorman Thomas E sold $14,244 worth of shares (50 units at $284.89) as part of a pre-agreed trading plan, decreasing direct ownership by 0.40% to 12,316 units (SEC Form 4)
- President/CEO/Chairman Dunbar David A. sold $3,780,607 worth of shares (13,000 units at $290.82) as part of a pre-agreed trading plan (SEC Form 4)
- Vice President Glass Alan J sold $421,730 worth of shares (1,391 units at $303.19), decreasing direct ownership by 6% to 22,723 units (SEC Form 4)
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)